<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Uterine Diseases</title>
    <link>http://www.newstin.com/us/uterine-diseases</link>
    <description>Global Social News Platform</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>OR-Live.com Presents: Surgical Tutorial on Complex da Vinci(R) Hysterectomy -- Strategies for...</title>
      <link>http://www.newstin.com/tag/us/75071971</link>
      <description>ANN ARBOR, MI, August 20 / MARKET WIRE/ -- OR-Live.com, the University of Michigan Health System and Intuitive Surgical, Inc. will present the second in a series of surgical tutorials on Complex da Vinci (robotic) Hysterectomy...</description>
      <pubDate>Wed, 20 Aug 2008 20:22:31 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/75071971</guid>
      <dc:date>2008-08-20T20:22:31Z</dc:date>
    </item>
    <item>
      <title>At midlife, a triumphant return</title>
      <link>http://www.newstin.com/tag/us/75121168</link>
      <description>Endometriosis knocked Melissa Emery out of last year's triathlon, but she's back By Janene Holzberg | Special to The Sun About a month before last summer's Iron Girl Triathlon, Melissa Emery was beset by debilitating fatigue....</description>
      <pubDate>Thu, 21 Aug 2008 04:00:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/75121168</guid>
      <dc:date>2008-08-21T04:00:00Z</dc:date>
    </item>
    <item>
      <title>Periods are awesome! A new study has found ... [Awesome]</title>
      <link>http://www.newstin.com/tag/us/74777941</link>
      <description>Periods are awesome! A new study has found that circulation-blocked mice, when injected with cells obtained from menstrual blood (called endometrial regenerative cells) their circulation and... [[ This is a content summary...</description>
      <pubDate>Tue, 19 Aug 2008 13:40:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74777941</guid>
      <dc:date>2008-08-19T13:40:00Z</dc:date>
    </item>
    <item>
      <title>PregLem Starts Phase III Trials Of PGL4001 In Uterine Myoma</title>
      <link>http://www.newstin.com/tag/us/74782816</link>
      <description>PregLem SA, a Swiss biopharmaceutical company specialized in reproductive medicine, announced the start of an international Phase III clinical trial program for PGL4001 (ulipristal) in symptomatic uterine myoma, a common benign...</description>
      <pubDate>Tue, 19 Aug 2008 14:17:11 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74782816</guid>
      <dc:date>2008-08-19T14:17:11Z</dc:date>
    </item>
    <item>
      <title>Goody leaves India</title>
      <link>http://www.newstin.com/tag/us/74720776</link>
      <description>Reality TV star Jade Goody has been diagnosed with cervical cancer, her publicist has confirmed. The 27-year-old was told whilst appearing on the Indian version of Big Brother, known as Bigg Boss. Max Clifford told BBC Radio...</description>
      <pubDate>Tue, 19 Aug 2008 07:55:40 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74720776</guid>
      <dc:date>2008-08-19T07:55:40Z</dc:date>
    </item>
    <item>
      <title>European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy</title>
      <link>http://www.newstin.com/tag/us/74706477</link>
      <description>Corporate news announcement processed and transmitted by Hugin ASA. MediGene AG (Frankfurt, Prime Standard: MDG) announces that the European Patent Office has granted a patent on the application of anti-L1 antibodies in cancer...</description>
      <pubDate>Tue, 19 Aug 2008 07:08:35 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74706477</guid>
      <dc:date>2008-08-19T07:08:35Z</dc:date>
    </item>
    <item>
      <title>Orcrist Bio Inc. Coauthors Groundbreaking Stem Cell Paper</title>
      <link>http://www.newstin.com/tag/us/74810586</link>
      <description>Use of Endometrial Regenerative Cells to Help Avoid Amputation CALGARY, Aug. 19 /CNW/ - Orcrist Bio Inc. a biotech company developing stem cell-mobilizing pharmaceuticals, has co-authored a peer reviewed publication with...</description>
      <pubDate>Tue, 19 Aug 2008 16:44:34 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74810586</guid>
      <dc:date>2008-08-19T16:44:34Z</dc:date>
    </item>
    <item>
      <title>Repros Therapeutics Inc. Provides Update for US Phase II Endometriosis Study and Completion of QT...</title>
      <link>http://www.newstin.com/tag/us/74529313</link>
      <description>THE WOODLANDS, Texas----Repros Therapeutics Inc. today announced that based on the robust efficacy demonstrated by Proellex® in the interim assessment of the Company's Phase II endometriosis study, there are sufficient patients...</description>
      <pubDate>Mon, 18 Aug 2008 13:42:58 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74529313</guid>
      <dc:date>2008-08-18T13:42:58Z</dc:date>
    </item>
    <item>
      <title>Trimedyne Enters Into Letter of Intent With FemSuite, LLC</title>
      <link>http://www.newstin.com/tag/us/74534841</link>
      <description>LAKE FOREST, CA--(Marketwire - August 18, 2008) - TRIMEDYNE, INC. (OTCBB: TMED) today announced it has entered into a Letter of Intent with FemSuite, LLC, a privately held company based in San Francisco which develops,...</description>
      <pubDate>Mon, 18 Aug 2008 13:30:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74534841</guid>
      <dc:date>2008-08-18T13:30:00Z</dc:date>
    </item>
    <item>
      <title>Trimedyne Enters Into Letter of Intent With FemSuite, LLC (Marketwire)</title>
      <link>http://www.newstin.com/tag/us/74529967</link>
      <description>Monday August 18, 9:30 am ET LAKE FOREST, CA--(MARKET WIRE)--Aug 18, 2008 -- News ) today announced it has entered into a Letter of Intent with FemSuite, LLC, a privately held company based in San Francisco which develops,...</description>
      <pubDate>Mon, 18 Aug 2008 13:46:16 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/74529967</guid>
      <dc:date>2008-08-18T13:46:16Z</dc:date>
    </item>
  </channel>
</rss>

